These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 31164420)

  • 1. NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer's models.
    Bahn G; Park JS; Yun UJ; Lee YJ; Choi Y; Park JS; Baek SH; Choi BY; Cho YS; Kim HK; Han J; Sul JH; Baik SH; Lim J; Wakabayashi N; Bae SH; Han JW; Arumugam TV; Mattson MP; Jo DG
    Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12516-12523. PubMed ID: 31164420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease.
    Chen CH; Zhou W; Liu S; Deng Y; Cai F; Tone M; Tone Y; Tong Y; Song W
    Int J Neuropsychopharmacol; 2012 Feb; 15(1):77-90. PubMed ID: 21329555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadd153 and NF-κB crosstalk regulates 27-hydroxycholesterol-induced increase in BACE1 and β-amyloid production in human neuroblastoma SH-SY5Y cells.
    Marwarha G; Raza S; Prasanthi JR; Ghribi O
    PLoS One; 2013; 8(8):e70773. PubMed ID: 23951005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
    Sadleir KR; Eimer WA; Cole SL; Vassar R
    Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer's disease mouse model.
    Shi Z; Hong Y; Zhang K; Wang J; Zheng L; Zhang Z; Hu Z; Han X; Han Y; Chen T; Yao Q; Cui H; Hong W
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2398-2407. PubMed ID: 28502705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease.
    Fukumoto H; Takahashi H; Tarui N; Matsui J; Tomita T; Hirode M; Sagayama M; Maeda R; Kawamoto M; Hirai K; Terauchi J; Sakura Y; Kakihana M; Kato K; Iwatsubo T; Miyamoto M
    J Neurosci; 2010 Aug; 30(33):11157-66. PubMed ID: 20720123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.
    Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.
    O'Connor T; Sadleir KR; Maus E; Velliquette RA; Zhao J; Cole SL; Eimer WA; Hitt B; Bembinster LA; Lammich S; Lichtenthaler SF; Hébert SS; De Strooper B; Haass C; Bennett DA; Vassar R
    Neuron; 2008 Dec; 60(6):988-1009. PubMed ID: 19109907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels.
    Deng QS; Dong XY; Wu H; Wang W; Wang ZT; Zhu JW; Liu CF; Jia WQ; Zhang Y; Schachner M; Ma QH; Xu RX
    Neuropsychopharmacology; 2016 Jan; 41(2):440-53. PubMed ID: 26062786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice.
    Devi L; Ohno M
    PLoS One; 2010 Sep; 5(9):e12974. PubMed ID: 20886088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon monoxide attenuates amyloidogenesis via down-regulation of NF-κB-mediated BACE1 gene expression.
    Kim HJ; Joe Y; Chen Y; Park GH; Kim UH; Chung HT
    Aging Cell; 2019 Feb; 18(1):e12864. PubMed ID: 30411846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling.
    Cho HJ; Jin SM; Youn HD; Huh K; Mook-Jung I
    Aging Cell; 2008 Mar; 7(2):137-47. PubMed ID: 18081741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
    Devi L; Ohno M
    Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krüppel-like factor 5 accelerates the pathogenesis of Alzheimer's disease via BACE1-mediated APP processing.
    Wang Y; Cui Y; Liu J; Song Q; Cao M; Hou Y; Zhang X; Wang P
    Alzheimers Res Ther; 2022 Jul; 14(1):103. PubMed ID: 35883144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms that lessen benefits of β-secretase reduction in a mouse model of Alzheimer's disease.
    Devi L; Ohno M
    Transl Psychiatry; 2013 Jul; 3(7):e284. PubMed ID: 23880880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
    Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
    Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer's disease.
    Bao J; Qin M; Mahaman YAR; Zhang B; Huang F; Zeng K; Xia Y; Ke D; Wang Q; Liu R; Wang JZ; Ye K; Wang X
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3954-3959. PubMed ID: 29581300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.